Browsing "Department of Clinical Oncology" by Author meng, y

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中
Showing results 6 to 11 of 11 < previous 
TitleAuthor(s)Issue DateViews
 
Modelling the Immunosuppressive Difference of SBRT and CRT by Simulating the Dose to Circulating Lymphocytes in Non-Small Cell Lung Cancer
Proceeding/Conference:Journal of Thoracic Oncology
Shen, YMeng, YTang, XGu, PYu, CWang, WKong, FPYang, H
2019
11
 
Modelling the Immunosuppressive Difference of SBRT and CRT by Simulating the Dose to Circulating Lymphocytes in Non-Small Cell Lung Cancer
Proceeding/Conference:Journal of Thoracic Oncology
Shen, YMeng, YTang, XGu, PYu, CWang, WKong, FPYang, H
2019
11
 
PHLPP1 Expression Through AKT and ERK Dual Signaling Pathways May Slow Down the Resistance to TKI in EGFR-Mutated Lung Adenocarcinoma
Proceeding/Conference:Journal of Thoracic Oncology
Wang, WLv, DMeng, YYe, MZhou, SKong, FPYang, H
2019
20
 
Radiation-induced lung damage in patients treated with stereotactic body radiotherapy after EGFR-TKIs: is there any difference from stereotactic body radiotherapy alone?
Journal:Annals of Palliative Medicine
Tang, XShen, YMeng, YHou, LZhou, CYu, CJia, HWang, WRen, GCai, JLi, XAYang, HKong, FP
2021
15
 
Surprisingly Promising Tumor Control Rate of S1 Combination with Anlotinib with Refractory Relapsed SCLC Who Failed ≥ 2 Lines Chemotherapy
Proceeding/Conference:Journal of Thoracic Oncology
Yang, HWang, WLv, DMeng, YZhou, SWu, XKong, FP
2019
27
 
Update Phase II Results of Early Primary Tumor Stereotactic Body Radiotherapy Combined with First-Line EGFR-TKI in Advanced EGFR Mutated NSCLC
Proceeding/Conference:Journal of Thoracic Oncology
Lv, DXu, HMeng, YWang, WWu, XKong, FPYang, H
2019
26
Showing results 6 to 11 of 11 < previous